Source:http://linkedlifedata.com/resource/pubmed/id/16426593
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-2
|
pubmed:dateCreated |
2006-4-17
|
pubmed:abstractText |
Tissue expression pattern of matrix metalloproteinases (MMPs) and their inhibitors TIMPs indicate that microvascular complications of diabetes mellitus are associated with extracellular matrix remodelling. We investigated whether circulating levels of MMP-9 and TIMP-1 are altered in diabetic retinopathy and whether they might serve as biological markers of ocular complications in type 1 diabetes.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0009-8981
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
367
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
103-7
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:16426593-Adult,
pubmed-meshheading:16426593-Aged,
pubmed-meshheading:16426593-C-Reactive Protein,
pubmed-meshheading:16426593-Diabetes Mellitus, Type 1,
pubmed-meshheading:16426593-Diabetic Retinopathy,
pubmed-meshheading:16426593-Female,
pubmed-meshheading:16426593-Humans,
pubmed-meshheading:16426593-Male,
pubmed-meshheading:16426593-Matrix Metalloproteinase 9,
pubmed-meshheading:16426593-Middle Aged,
pubmed-meshheading:16426593-Tissue Inhibitor of Metalloproteinase-1
|
pubmed:year |
2006
|
pubmed:articleTitle |
Elevated circulating levels of matrix metalloproteinase-9 in type 1 diabetic patients with and without retinopathy.
|
pubmed:affiliation |
Service de Diabétologie, Groupe Hospitalier Pitié-Salpêtrière, 47-83 boulevard de l'hôpital, F75651 Paris Cedex 13, France. sophie.jacqueminet@psl.aphp.fr
|
pubmed:publicationType |
Journal Article
|